Skip to Main Content

About me

She | Her | Hers

Dr. Mary Feng is a radiation oncologist who cares for patients with cancers affecting organs of the abdomen and pelvis.

In research, Feng aims to refine radiation therapy so that it's more effective and has fewer side effects through the use of advanced technologies and imaging techniques. Her work includes improving radiation treatment when used alone as well as in combination with chemotherapy and immunotherapy.

As vice chair for clinical research in the Department of Radiation Oncology, Feng supervises and encourages innovative clinical trials at UCSF. As the medical director of the Clinical Research Network Office at the Helen Diller Family Comprehensive Cancer Center, she helps local UCSF partners expand clinical trials into the community.

Feng earned her medical degree at Washington University School of Medicine in St. Louis. She completed a residency in radiation oncology at the University of Michigan Hospitals.

  • Board Certifications

    American Board of Radiology, Radiation Oncology, 2008

  • Residencies

    University of Michigan Hospitals and Health Centers, Radiation Oncology, 2007

  • Internship

    University of Michigan Hospitals and Health Centers, Internal Medicine, 2003

  • Education

    Washington University School of Medicine, 2002

  • Languages

    English

I am motivated to improve the lives of patients and families today – and impact many more in the future.

Where I see patients (3)

    Decorative Caduceus

    Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

    Proportion of patients who achieve as their best overall response according to Response Evaluation Criteria in Solid Tumors (RECIST) v. 1.1 criteria: Stable disease (SD), partial response (PR), confirmed Complete Response (CR), or...

    Recruiting

    Decorative Caduceus

    Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Can...

    Defined per Response Evaluation Criteria in Solid Tumors 1.1, excluding radiation therapy-treated lesions. assessed from initiation of study treatment until discontinuation of treatment. Proportion of response and corresponding ex...

    Recruiting

    Share